Delivery Order SPE2DB22D3501-SPE2DB25FWB27
Award Date
6/16/25
Potential Completion Date
7/9/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,530.00 contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a performance period through December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a $3,662.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 10 gram/100 ml vials, a pharmaceutical product, with an ultimate completion date of July 1, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a $3,005.70 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 10 gram/100 ml vials. The contract has a completion date of October 29, 2024 and does not utilize any set-aside designations. Amerisourcebergen, through its extensive supply chain network, provides a wide range of prescription medications, medical supplies, and other healthcare products to support various...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,052.40 contract is for the delivery of GAMUNEX-C 10 gram/100 ml vials, with a performance period through June 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a $54,795.26 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a period of performance through March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,843 units of the pharmaceutical product GAMUNEX-C 20 gram/200 ml vial. The contract has a ceiling value of $7,147.50 and a period of performance through April 22, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,315.12 contract is for the supply of GAMUNEX-C 40 gram/400 ml vials to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of January 12, 2024. This delivery order is...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The $11,912.50 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.46 firm fixed-price contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a completion date of December 30, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a ceiling value of $13,963.20 and an ultimate completion date of June 6, 2025. The contract is not set-aside and was awarded on May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...